Table 1. Characteristics of 25 patients (39 tumors) treated for hepatocellular carcinoma with radiotherapy

Age (years)^a

60.7 (40.7 to 76.2)

Gender [cases (%)]

  Men

18 (72)

  Women

7 (28)

ECOG performance status [cases (%)]

  0

10 (40)

  1

11 (44)

  2

4 (16)

Underlying hepatitis [cases (%)]

  B

20 (80)

  C

2 (8)

  Alcoholic

1 (4)

  No hepatitis

2 (8)

Child-Pugh classification [cases (%)]

  A

19 (76)

  B

6 (24)

Tumor size (cm) ^a

1.7 (0.7 to 16.3)

GTV (cm³) ^a

6.84 (0.72 to 114.7)

T category [cases (%)]

  1

1 (4)

  2

12 (48)

  3

12 (48)

Pre-radiotherapy AFP concentration (IU/mL) ^a

25.94 (1.42 to 34,132)

AFP concentration change ^a

0.9 (0.01 to 1,132.5)

Total radiotherapy dose (Gy) ^a

55.0 (40.0 to 60.0)

Daily radiotherapy dose (Gy) ^a

2.5 (2 to 4)

Biologically equivalent dose (Gy10) ^a

67.1 (56.0 to 78.0)

Previous TACE [number of tumors (%)]

  Yes

23 (58.9)

  No

16 (41.1)

Interval between radiotherapy and TACE (months) ^a

3.2 (0.5 to 13.0)